Patient and transplant outcome in infants starting renal replacement therapy before 2 years of age

Julien Hogan1,2, Justine Bacchetta3, Marina Charbit4

  • 1Pediatric Nephrology Department, Robert Debré University Hospital, APHP, Paris, France.

Insights

Children needing renal replacement therapy (RRT) before age two have good survival rates. Extrarenal comorbidities increase mortality risk, while optimal donor matching improves graft survival post-transplantation.

Area of Science:

  • Pediatric Nephrology
  • Renal Replacement Therapy
  • Organ Transplantation

Background:

  • Management of children requiring renal replacement therapy (RRT) before two years of age presents challenges.
  • Transplantation is often delayed until children reach 10 kg or two years old.
  • This study addresses patient and graft survival in this pediatric population.

Purpose of the Study:

  • To evaluate patient and graft survival in children initiating RRT before 24 months of age.
  • To provide data to guide RRT initiation and transplantation management decisions for young children.
  • To identify factors influencing survival and transplantation outcomes in this cohort.

Main Methods:

  • A national cohort study included children starting RRT before 24 months of age between 1992 and 2012 in France.
  • Data were collected through the national Renal Epidemiology and Information Network (REIN) registry.
  • Primary endpoints were patient survival on dialysis and 10-year graft survival.

Main Results:

  • The 10-year survival rate for the 224 included children was 84%.
  • Extrarenal comorbidities were associated with increased mortality risk on dialysis and reduced transplantation probability.
  • 10-year graft survival was 74%, with factors like time on dialysis, donor/recipient height mismatch, and HLA-DR mismatches impacting graft loss.

Conclusions:

  • Children starting RRT before two years of age demonstrate good outcomes.
  • Optimal timing and methods for transplantation in this group require careful consideration.
  • Findings offer data on morphological and immunological matching to aid clinical decision-making.
Abstract

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.1K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
234
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
241
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
713
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
265
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
227